Command Palette

Search for a command to run...

LINCOLN

524-0.92%
Market Cap
₹1,058.67 Cr
Stock P/E
12.26
ROCE
17.55%
ROE
13.02%
Book Value
₹349.15

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

POSITIVES
  • Debt-free balance sheet and internal capex discipline indicate strong financial footing for future expansion.
  • Regulatory and geographic diversification gains through EU approval and Canada/Australia market entries support future growth.
NEGATIVES
  • Gross margin pressure and short-term margin volatility raise questions about near-term profitability stability.
  • Cyclicality around the March quarter indicated by history comments; persistent seasonality affecting top line and margins.

Peers Summary

Sector Leader

Lincoln Pharmaceuticals Ltd. stands out among its peers with strong revenue growth, robust profitability metrics, and low debt levels, indicating a solid performance in the Pharmaceuticals & Drugs sector. Its valuation ratios also suggest it is attractively priced compared to its peers, making it a compelling pick for investors looking for growth and value.

Key Points
  • Lincoln Pharmaceuticals has the highest revenue growth (YoY) at 13.76%.
  • It boasts the lowest debt-to-equity ratio at 0.0018, indicating strong financial stability.
  • The company has an attractive PEG ratio of 0.32, suggesting good growth potential relative to its price.
Top Performers
Lincoln Pharmaceuticals Ltd.

Strong revenue growth and low debt levels make it a leader in the sector.

Dr. Reddy's Laboratories Ltd.

High profitability with solid ROE and low valuation metrics make it a good pick.

Mankind Pharma Ltd.

Outstanding revenue growth of 155.25% over three years, indicating strong market demand.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.